we see big pharma going after smaller biotechs in 2024, says jefferies' michael yee

Published 9 months ago • 6.6K plays • Length 5:58

Download video MP4
Download video MP3

Similar videos

3:34

pharma could see a wave of m&a activity in 2024, says jefferies' michael yee
2:46

biotech will face challenges this year, says jefferies' michael yee
4:18

biotech stocks have been overlooked for the past year and a half, says jefferies' michael yee
2:31

we still think there's more room for biotech to go higher, says jefferies' yee
4:19

‘one of the biggest deficits’: labor expecting $43 billion deficit in two years
41:28

where are laid off tech employees going? | cnbc marathon
6:34

'i'm not concerned about my job! we're in the same boat!' ✌ erik ten hag ⚽ man utd 0-3 tottenham
4:43

直擊 ! 上石岐行盒馬鮮生 ! 99元一隻波龍金枕23.9元/斤
4:22

covid is going to be a problem for the stocks of vaccine makers, says jefferies' michael yee
3:33

jefferies' michael yee still likes amgen in the biotech sector
4:38

congress pushes to lower the price of weight loss drugs
3:20

jefferies' michael yee expects big opportunities for a.i. in the biotech sector
5:00

jefferies michael yee explains why he is bullish on biotech in 2022
3:43

use market volatility to add stock, says main street research's james demmert
5:50

i am feeling a 'little more optimistic' on the consumer sector, says kayne anderson's julie biel
4:15

the oil market today doesn't preemptively price in risk, says s&p global's dan yergin
3:01

biogen's alzheimer's drug is the biggest growth catalyst for the stock, says jefferies' yee
4:31

jefferies' michael yee expects amgen's horizon therapeutics deal will go through despite ftc block
4:30

ge vernova: here's why jefferies' julien dumoulin-smith is bullish on the stock
2:57

jefferies' michael yee explains his top biotech picks: vrtx, fate, zlab
6:34

there's valuation opportunities here for china, says neuberger berman's conrad saldanha
0:06

get half price off vitamins at chemist warehouse!

Clip.africa.com - Privacy-policy